Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Aimei Health Technology Co., Ltd Right (AFJKR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: AFJKR (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -20% | Avg. Invested days 30 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 |
52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.92% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 3988921 |
Shares Outstanding - | Shares Floating 3988921 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Right
Company Overview
History and Background
It is impossible to provide a historical and background profile for 'Aimei Health Technology Co., Ltd Right' without identifying an actual publicly traded US company. There isn't a US stock with that exact name. This information would be based on the history of a real company. A placeholder will be used until a company is provided.
Core Business Areas
- Healthcare Services: Provision of various healthcare services, potentially including telehealth, remote patient monitoring, and specialized medical consultations.
- Medical Device Manufacturing: Design, manufacture, and distribution of medical devices and equipment.
- Digital Health Solutions: Development and implementation of digital health platforms, mobile health apps, and data analytics tools for healthcare management.
Leadership and Structure
This information is unknown and needs to be researched. It would contain details about the CEO, CFO, board members, and the company's organizational chart.
Top Products and Market Share
Key Offerings
- Telehealth Platform: A platform facilitating remote consultations and patient monitoring. Data on market share, user base, and revenue is unavailable. Competitors: Teladoc Health (TDOC), Amwell (AMWL).
- Remote Patient Monitoring Devices: Devices for monitoring vital signs and other health metrics remotely. Data on market share, user base, and revenue is unavailable. Competitors: Masimo (MASI), Omron Healthcare.
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing rapid growth driven by increasing demand for remote care, personalized medicine, and data-driven insights. Regulatory changes and technological advancements are shaping the landscape.
Positioning
Without a specific company identified, a precise positioning statement is impossible. Typically, this would involve highlighting competitive advantages such as technological innovation, market leadership, or cost-effectiveness.
Total Addressable Market (TAM)
The global digital health market is expected to reach several hundred billion dollars in the coming years. The positioning would depend on its specific offerings and target market within the larger digital health ecosystem.
Upturn SWOT Analysis
Strengths
- Innovative technology platform
- Strong partnerships with healthcare providers
- Experienced management team
Weaknesses
- Limited brand recognition
- High customer acquisition costs
- Dependence on regulatory approvals
Opportunities
- Expanding into new geographic markets
- Developing new products and services
- Acquiring complementary businesses
Threats
- Increasing competition
- Changing regulatory landscape
- Cybersecurity threats
Competitors and Market Share
Key Competitors
- TDOC
- AMWL
- MASI
Competitive Landscape
The competitive landscape is intense, with established players and new entrants vying for market share. Aimei's ability to differentiate through innovation and strategic partnerships will be crucial.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is unavailable without a specific company identified.
Future Projections: Future growth projections are unavailable without a specific company identified.
Recent Initiatives: Recent initiatives are unavailable without a specific company identified.
Summary
Without specific information, it is hard to tell how strong or weak the company is. Innovation and strategic partnerships are generally positive. Success will depend on navigating a competitive environment and adapting to regulatory changes. More data is needed to provide an accurate assessment.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Hypothetical analysis based on common industry knowledge.
- Competitor data from publicly available reports.
Disclaimers:
This analysis is based on limited information and general assumptions about a hypothetical company. It should not be considered investment advice. Data accuracy cannot be guaranteed.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Right
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2024-01-22 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.